Louis W. Sullivan - 24 Jul 2025 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol
UTHR
Transactions as of
24 Jul 2025
Net transactions value
$0
Form type
4
Filing time
28 Jul 2025, 06:21:46 UTC
Previous filing
02 May 2025
Next filing
23 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
SULLIVAN LOUIS W Director C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING /s/ John S. Hess, Jr. under Power of Attorney 25 Jul 2025 0001193522

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $0 +590 $0.000000 590 25 Jul 2025 by Trust F1, F2
holding UTHR Common Stock 3,200 24 Jul 2025 by Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Restricted Stock Unit Options Exercise $0 -590 -100% $0.000000 0 25 Jul 2025 Common Stock 590 $0.000000 by Trust F1, F3, F4
transaction UTHR Restricted Stock Unit Award $0 +650 $0.000000 650 24 Jul 2025 Common Stock 650 $0.000000 Direct F3, F5, F6
transaction UTHR Stock Options Award $0 +1,830 $0.000000 1,830 24 Jul 2025 Common Stock 1,830 $306.41 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock.
F2 These common stock shares are held indirectly by a trust over which the reporting person has sole investment power and sole voting power.
F3 Not applicable as restricted stock units do not have an expiration date.
F4 These restricted stock units were held indirectly by a trust over which the reporting person has sole investment power and sole voting power.
F5 Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
F6 Annual non-employee director award.